Back to Search Start Over

Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies.

Authors :
Leroux E
Perbet R
Caillierez R
Richetin K
Lieger S
Espourteille J
Bouillet T
Bégard S
Danis C
Loyens A
Toni N
Déglon N
Deramecourt V
Schraen-Maschke S
Buée L
Colin M
Source :
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2022 Feb 02; Vol. 30 (2), pp. 782-797. Date of Electronic Publication: 2021 Sep 24.
Publication Year :
2022

Abstract

Tauopathies are neurodegenerative diseases characterized by tau inclusions in brain cells. Seed-competent tau species have been suggested to spread from cell to cell in a stereotypical manner, indicating that this may involve a prion-like mechanism. Although the intercellular mechanisms of transfer are unclear, extracellular vesicles (EVs) could be potential shuttles. We assessed this in humans by preparing vesicles from fluids (brain-derived enriched EVs [BD-EVs]). These latter were isolated from different brain regions in various tauopathies, and their seeding potential was assessed in vitro and in vivo. We observed considerable heterogeneity among tauopathies and brain regions. The most striking evidence was coming mainly from Alzheimer's disease where the BD-EVs clearly contain pathological species that can induce tau lesions in vivo. The results support the hypothesis that BD-EVs participate in the prion-like propagation of tau pathology among tauopathies, and there may be implications for diagnostic and therapeutic strategies.<br />Competing Interests: Declaration of interests The authors declare no competing interests.<br /> (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1525-0024
Volume :
30
Issue :
2
Database :
MEDLINE
Journal :
Molecular therapy : the journal of the American Society of Gene Therapy
Publication Type :
Academic Journal
Accession number :
34563677
Full Text :
https://doi.org/10.1016/j.ymthe.2021.09.020